Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
Cancer Medicine · 2025
DOI: 10.1002/cam4.70467 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Shu Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Lianshui People's Hospital Affiliated to Kangda College of Nanjing Medical University, Huai'an, China. Hauptthemen laut MEDLINE: Cytodiagnosis, Early Detection of Cancer, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Elderly Health Research Project, Huai'an Health Research Project.
Abstract (Originalsprache)
Objective
To investigate the feasibility and accuracy of esophageal sponge cytology in screening esophageal squamous cell carcinoma (ESCC).
Methods
From May 2021 to June 2022, an opportunistic screening was performed in people aged 40–75 from a high‐risk region for ESCC. Using an esophageal cell collector that was independently developed in China for esophageal sponge cytology, a positive cytology was determined as detection of atypical squamous cells or more severe lesions. The safety, tolerability, and accuracy of esophageal sponge cytology were compared with those of pathological examination after endoscopy and biopsy.
Results
A total of 1581 eligible participants were involved in the screening program, including 61 (3.86%) with high‐grade lesions pathologically confirmed by endoscopic biopsy. No serious adverse events were reported during sampling. Major adverse events included vomiting during sampling ( n = 2, 0.13%) and sore throat after sampling ( n = 36, 2.27%). The majority of participants showed good tolerability and accessibility ( n = 1568, 98.80%) accessed by the visual analogue scale (VAS). Esophageal sponge cytology offered a satisfactory diagnostic accuracy in screening advanced esophageal epithelial lesions, with a sensitivity of 98.36% (95%CI: 90.02%–99.91%) and a specificity of 91.15% (95%CI: 89.97%–92.84%), and a negative predictive value up to 99. 92% (95%CI: 99.53%–99.99%).
Conclusion
Esophageal sponge cytology is a highly feasible, safe, and accurate screening method for ESCC in a high‐risk region of China. Trial Registration First Affiliated Hospital of Naval Medical University: NCT04609813
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Lianshui People's Hospital Affiliated to Kangda College of Nanjing Medical University, Huai'an, China.
- Cancer Institute of Jiangsu Province, Jiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
- Department of Gastroenterology, Zhongda Hospital, Southeast University, Nanjing, China.
ORCID-Profile: Xuexiang Gu
Förderung
- Jiangsu Province Elderly Health Research Project
- Huai'an Health Research Project
Zitieren
APA
Huang, S., Gu, X., Zhou, H., Feng, Y., Shi, R., Wang, W., Zhou, A., & Lin, J. (2025). Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China. Cancer Medicine. https://doi.org/10.1002/cam4.70467
Vancouver
Huang S, Gu X, Zhou H, Feng Y, Shi R, Wang W, et al. Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China. Cancer Medicine. 2025. doi:10.1002/cam4.70467
BibTeX
@article{Huang2025,
author = {Huang, Shu and Gu, Xuexiang and Zhou, Hailang and Feng, Yadong and Shi, Ruihua and Wang, Wei and Zhou, Aijun and Lin, Jie},
title = {Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70467}
}
EUVIMED